Loneliness, Depression, Anxiety, and Post-traumatic Stress Disorder Among Chinese Adults During COVID-19: A Cross-sectional Online Survey
Overview
Authors
Affiliations
Objectives: This study aims to investigate the potential factors associated with mental health outcomes among Chinese adults during the Coronavirus disease 2019 (COVID-19) epidemic.
Methods: This is an online cross-sectional survey conducted among Chinese adults in February 2020. Outcome measurements included the three-item UCLA Loneliness Scale (UCLA-3), two-item Patient Health Questionnaire (PHQ-2), two-item Generalized Anxiety Disorder Questionnaire (GAD-2), and two items from the Clinician-Administered Post-traumatic Stress Disorder (PTSD) Scale. COVID-19 related factors, physical health, lifestyle, and self-efficacy were also measured. Univariable and multivariable logistic regressions were performed.
Results: This study included 1456 participants (age: 33.8±10.5 years; female: 59.1%). The prevalence of depressive symptoms, anxiety symptoms, loneliness, and PTSD symptoms were 11.3%, 7.6%, 38.7%, and 33.9%, respectively. In multivariable analysis, loneliness was associated with being single, separated/divorced/widowed, low level of education, current location, medication, more somatic symptoms, lower self-efficacy, and going out frequently. Depression was associated with fear of infection, binge drinking, more somatic symptoms, lower self-efficacy, and longer screen time. Anxiety was associated with more somatic symptoms and lower self-efficacy. PTSD symptoms were associated with more somatic symptoms, lower self-efficacy, higher perceived risk of infection, fear of infection, and self-rated more negative influence due to the epidemic (p<0.05).
Conclusions: Mental health problems during the COVID-19 epidemic were associated with various biopsychosocial and COVID-19 related factors. Psychological interventions should be aware of these influencing factors and prioritize support for those people at higher risk.
Yanping D, Yanping W, Qian H, Wei L, Borui S, Baker J BMC Public Health. 2024; 24(1):3222.
PMID: 39567997 PMC: 11577599. DOI: 10.1186/s12889-024-20516-7.
Bin X, Qu K, Wang Y, Chen L, Xiong Y, Wen J Front Public Health. 2024; 11:1267764.
PMID: 38249392 PMC: 10796455. DOI: 10.3389/fpubh.2023.1267764.
Yuan L, Yibo W, Yuqian D, Haiye R, Jiaxin L, Liping Z Front Psychiatry. 2023; 14:1204544.
PMID: 37614652 PMC: 10442840. DOI: 10.3389/fpsyt.2023.1204544.
Reangsing C, Trakooltorwong P, Maneekunwong K, Thepsaw J, Oerther S BMC Complement Med Ther. 2023; 23(1):269.
PMID: 37507747 PMC: 10386675. DOI: 10.1186/s12906-023-04102-9.
da Silva S, Carvalho L, Braga F, Silveira R, Santos O Front Psychiatry. 2023; 14:1151253.
PMID: 37492069 PMC: 10364444. DOI: 10.3389/fpsyt.2023.1151253.